Mycophenolate Mofetil
Mycophenolate Mofetil is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Mycophenolate Mofetil; Generic name: MYCOPHENOLATE MOFETIL; Manufacturer: Camber Pharmaceuticals, Inc..
| Brand name | Mycophenolate Mofetil |
|---|---|
| Generic name | MYCOPHENOLATE MOFETIL |
| Manufacturer | Camber Pharmaceuticals, Inc. |
| Used for | 1 INDICATIONS AND USAGE Mycophenolate mofetil capsules are indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1) ], heart [see Clinical Studies (14.2) ] or liver transplants [see Clinical Studies (14.3) ], in combination with other immunosuppressants. Mycophenolate Mofetil capsules are an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION ADULTS DOSAGE Kidne y Transplant 1 g twice daily orally ( 2.2 ) Heart Transplant 1.5 g twice daily orally ( 2.3 ) L i ve r Transplant 1.5 g twice daily orally ( 2.4 ) PEDIATRICS Kidne y Transplant 600 mg/m 2 orally twice daily, up to maximum of 2 g daily ( 2.2 ) Heart Transplant 600 mg/m 2 orally twice daily (starting dose) up to a maximum of 900 mg/m 2 twice daily (3 g) ( 2.3 ) Liver Transplant 600 mg/m 2 orally twice daily (starting dose) up to a maximum of 900 mg/m |
| Warnings | WARNING: EMBRYOFETAL TOXICITY, MALIGNANCIES and SERIOUS INFECTIONS • Use during pregnancy is associated with increased risks of first trimester pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning [see Warnings and Precautions (5.1) , Use in Special Populations (8.1 , 8.3 )]. • Increased risk of development of lymphoma and other malignancies, particularly of the |
| Active ingredient(s) | MYCOPHENOLATE MOFETIL |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=118e9bc8-c1a9-41d0-89e6-251f3be0b99c |